PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 176 filers reported holding PRECIGEN INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,908,297 | +38.0% | 1,343,872 | +11.7% | 0.00% | – |
| Q2 2023 | $1,383,157 | +7.6% | 1,202,746 | -0.8% | 0.00% | – |
| Q1 2023 | $1,286,000 | +71823.9% | 1,212,494 | +3.1% | 0.00% | – |
| Q4 2022 | $1,788 | -99.9% | 1,176,132 | -0.5% | 0.00% | – |
| Q3 2022 | $2,505,000 | +8.8% | 1,181,824 | -31.2% | 0.00% | – |
| Q2 2022 | $2,302,000 | -37.8% | 1,717,421 | -2.1% | 0.00% | – |
| Q1 2022 | $3,702,000 | -47.7% | 1,754,308 | -8.0% | 0.00% | -100.0% |
| Q4 2021 | $7,078,000 | -23.0% | 1,907,696 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $9,194,000 | -16.1% | 1,842,588 | +9.6% | 0.00% | 0.0% |
| Q2 2021 | $10,964,000 | +24.7% | 1,681,724 | +31.8% | 0.00% | 0.0% |
| Q1 2021 | $8,789,000 | +11.9% | 1,275,572 | +65.6% | 0.00% | 0.0% |
| Q4 2020 | $7,857,000 | +312.9% | 770,231 | +43.2% | 0.00% | – |
| Q3 2020 | $1,903,000 | +13.8% | 537,846 | +60.5% | 0.00% | – |
| Q2 2020 | $1,672,000 | +96.9% | 335,026 | +34.2% | 0.00% | – |
| Q1 2020 | $849,000 | – | 249,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |